APA (7th ed.) Citation

JN, L., AM, H., JS, H., A, T., & JS, P. (2022). Neurocognitive risk in sickle cell disease: Utilizing neuropsychology services to manage cognitive symptoms and functional limitations. British journal of haematology, 197(3), 260. https://doi.org/10.1111/bjh.18041

Chicago Style (17th ed.) Citation

JN, Longoria, Heitzer AM, Hankins JS, Trpchevska A, and Porter JS. "Neurocognitive Risk in Sickle Cell Disease: Utilizing Neuropsychology Services to Manage Cognitive Symptoms and Functional Limitations." British Journal of Haematology 197, no. 3 (2022): 260. https://doi.org/10.1111/bjh.18041.

MLA (9th ed.) Citation

JN, Longoria, et al. "Neurocognitive Risk in Sickle Cell Disease: Utilizing Neuropsychology Services to Manage Cognitive Symptoms and Functional Limitations." British Journal of Haematology, vol. 197, no. 3, 2022, p. 260, https://doi.org/10.1111/bjh.18041.